Bafna Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar' 24	Dec' 23	Sep' 23	Jun' 23	Mar' 23

Sales

41.40

28.44

40.68

41.95

42.24

Operating profit

2.89

-2.08

4.00

6.30

7.62

Interest

0.68

0.58

0.44

0.60

0.70

Gross profit

2.73

-1.67

3.73

7.56

7.18

EPS (Rs)

0.62

-1.24

1.05

2.68

2.27

Other income

0.52

0.98

0.16

1.87

0.26

Stock adjustment

-3.37

-0.19

2.24

-3.53

1.36

Raw material

23.79

16.00

19.67

19.56

19.72

Power and fuel

-

-

-

-

-

Employee expenses

5.38

4.53

4.85

4.27

4.57

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

12.72

10.19

9.92

15.34

8.97

Provisions made

-

-

-

-

-

Depreciation

1.27

1.27

1.24

1.21

1.53

Taxation

-

-

-

-

0.28

Net profit / loss

1.46

-2.94

2.48

6.35

5.37

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

23.66

23.66

23.66

23.66

23.66

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

6.97

-7.30

9.84

15.01

18.04

GPM (%)

6.51

-5.68

9.12

17.26

16.88

NPM (%)

3.47

-10.00

6.08

14.49

12.64